Transcriptomics

Dataset Information

0

The predictive biomarkers of TNFα-blocking agent responsiveness are specific for adalimumab and etanercept


ABSTRACT: The objective of this study was to identify specific gene expression profiles able to predict the response of rheumatoid arthritis patients treated with methotrexate (MTX)/adalimumab (ADA) or MTX/etanercept (ETA). Twenty RA patients were received subcutaneously Adalimumab (40 mg each other week) and eleven RA patients were received Etanercept (50 mg per week). The drug efficacy was evaluated with the DAS28 score after 3 months of treatment according to the EULAR response criteria. A blood sample was carried out in patients just before the first injection of treatment in order to isolate peripheral blood mononuclear cells (PBMC) and extract total RNA.

ORGANISM(S): Homo sapiens

PROVIDER: GSE42842 | GEO | 2024/03/22

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2009-04-15 | E-GEOD-15602 | biostudies-arrayexpress
2009-04-15 | GSE15602 | GEO
2014-01-29 | GSE35455 | GEO
2014-01-29 | E-GEOD-35455 | biostudies-arrayexpress
| EGAS00001007578 | EGA
2017-05-17 | E-GEOD-68215 | biostudies-arrayexpress
2017-05-17 | GSE68215 | GEO
2020-07-24 | GSE91079 | GEO
2021-11-11 | GSE188509 | GEO
2020-08-24 | GSE138746 | GEO